Tazarotene Cream, 0.1%

DRUG2 trials

Sponsors

Galderma R&D, Dr. Reddy's Laboratories Limited

Conditions

Acne Vulgaris

Phase 2

A Bioavailability Study of DFD-03 Compared to Tazorac® in Patients With Moderate Acne Vulgaris

CompletedNCT03599193

Dr. Reddy's Laboratories LimitedAcne Vulgaris

Start: 2017-10-04End: 2018-04-30Updated: 2021-03-01

Phase 4

Differin® Gel x12 Wks vs Tazorac® Cream x12 Wks vs Differin® x6 Wks Switched to Tazorac® x6 Wks for Treatment of Acne

CompletedNCT00469755

Galderma R&DAcne Vulgaris

Start: 2006-02-28End: 2006-09-30Updated: 2022-07-29